Testing for B12 Deficiency: What to Know
B12 deficiency is easy to miss and easy to treat, but testing has some quirks.
By Ryan Bennett | Reviewed for accuracy by Marco Alvarez | Last updated August 18, 2026
In this guide
- What B12 does and why a shortfall is easy to miss
- Who is actually at elevated risk
- The serum B12 test and its blind spots
- Methylmalonic acid and homocysteine as follow-up markers
- Things that distort your result
- At-home B12 panels versus a lab draw
- Reading your result and what comes next
- Frequently asked questions
Key takeaways
- Serum B12 is the standard first test, but it is an imperfect measure. Results in the low-normal range are genuinely ambiguous.
- Methylmalonic acid is the more sensitive follow-up marker. It rises when B12 is functionally low at the cellular level.
- Highest risk groups: people over about 60, long-term vegans and vegetarians, metformin users, long-term acid-reducer users, and people with gastric or intestinal surgery or autoimmune gastritis.
- Neurological symptoms can appear before anemia does, so a normal blood count does not rule out a problem.
- Biotin supplements and recent B12 intake can both distort results. Timing matters.
Vitamin B12 deficiency has an unusual profile among nutrient problems. It is common enough that most clinicians see it regularly, it is inexpensive to correct, and yet it is routinely missed for months or years. Part of the reason is that the symptoms are unglamorous and easily attributed to something else. Fatigue, brain fog, tingling in the hands or feet, low mood, and unsteadiness on your feet describe a hundred conditions. Part of the reason is that the standard test itself is less decisive than a single number on a lab report suggests.
The stakes justify a careful approach. Untreated B12 deficiency can cause damage to the spinal cord and peripheral nerves that becomes permanent if it goes on long enough. Caught early, it is often reversible with oral supplementation or injections. That gap between reversible and permanent is the reason testing is worth understanding rather than just ordering.

What B12 does and why a shortfall is easy to miss
B12 is a cofactor in two reactions. One converts homocysteine to methionine, feeding the methylation processes that DNA synthesis depends on. The other converts methylmalonyl-CoA to succinyl-CoA in mitochondria. When B12 runs short, the substrates in front of these blocked steps back up, which is exactly what makes them useful as test markers. Both reactions matter to nerve tissue, which is why the neurological picture can be prominent.
The liver stores a substantial reserve, often enough for a few years of low intake. That storage capacity is why a vegan diet does not produce symptoms in the first month and why a deficiency, once it develops, has usually been building quietly for a long time. It also means blood levels can drift downward well before anything feels wrong, and that testing catches problems earlier than waiting for symptoms would.
Who is actually at elevated risk
Age is the largest single factor in the general population. Absorbing B12 from food requires stomach acid to release it from protein and requires intrinsic factor to carry it across the intestinal wall. Both decline with age, and atrophic gastritis becomes more common. Estimates of deficiency or borderline status in adults over 60 vary by definition and population but consistently run into the several percent range and higher, which is not a niche problem.
Diet is the other obvious axis. B12 is produced by bacteria and reaches humans almost entirely through animal foods or fortification, so long-term vegans who do not supplement or eat fortified products will eventually run down their stores. Beyond those two groups: metformin interferes with B12 absorption over years of use, proton pump inhibitors and H2 blockers reduce the acid needed to liberate food-bound B12, and gastric bypass, sleeve gastrectomy, or ileal resection remove parts of the absorption machinery. Pernicious anemia, an autoimmune loss of intrinsic factor, is the classical cause and requires lifelong treatment.
The serum B12 test and its blind spots
A serum or plasma total B12 test is what almost every panel starts with. It is cheap, widely available, and reasonable as a screen. Most labs flag results below roughly 200 picograms per milliliter as deficient and treat anything above about 200 to 250 as normal, though reference ranges differ between labs enough that comparing numbers across providers is unreliable.
The blind spot is the grey zone. Values between roughly 200 and 400 are common and poorly discriminating. Plenty of people in that band are fine, and plenty have real functional deficiency, because total serum B12 measures all circulating B12 including the large fraction bound to haptocorrin that cells cannot use. Only the portion bound to transcobalamin, sometimes measured separately as holotranscobalamin or active B12, is available for uptake. A person can carry a normal-looking total while their cells are short. Conversely, liver disease and some blood disorders can push the total up and hide a deficiency entirely.
Methylmalonic acid and homocysteine as follow-up markers
When the serum result lands in the ambiguous band and the clinical picture raises suspicion, methylmalonic acid is the standard next step. Because MMA accumulates specifically when the B12-dependent mitochondrial step is blocked, an elevated MMA with a borderline B12 is fairly convincing evidence of functional deficiency. It can be measured in serum or urine. Its main confounder is kidney function, since impaired clearance raises MMA independent of B12 status.
Homocysteine also rises in B12 deficiency, but it is less specific. Folate deficiency, B6 deficiency, kidney disease, hypothyroidism, and common genetic variants all push homocysteine up, so an elevated value narrows the field without naming the culprit. It is most useful alongside MMA rather than instead of it. If MMA is high and homocysteine is normal, B12 is the likely issue rather than folate. Because folate and B12 problems produce identical changes in red blood cells, the two are usually evaluated together, and our guide on folate versus folic acid explains why generous folate can hide a B12 problem on a blood count.
Things that distort your result
Biotin is the most common and most preventable source of a wrong answer. High-dose biotin, the kind sold in hair and nail supplements at 5,000 or 10,000 micrograms, interferes with the biotin-streptavidin chemistry used in many immunoassays and can shift B12 and thyroid results in either direction depending on the assay design. Most labs advise stopping biotin for at least two to three days before a draw, and longer for very high doses. This one factor probably accounts for a meaningful share of confusing results.
Recent supplementation is the other big one. If you started a B12 supplement two weeks ago, your serum level reflects the supplement rather than your underlying absorption capacity, and a normal result tells you very little. If the question is whether you have a long-term absorption problem, testing while actively supplementing is close to pointless. Pregnancy lowers serum B12 without necessarily indicating deficiency, and oral contraceptives can lower it modestly as well. For a broader look at how to prepare for and interpret any blood panel, see our overview of at-home versus lab testing.
At-home B12 panels versus a lab draw
At-home kits generally use a finger-prick dried blood spot mailed to a partner laboratory, and many of them run in CLIA-certified facilities using recognized methods. For a first look at whether your total B12 sits comfortably in range, they can do the job, and they remove the friction of booking an appointment. That convenience is real, especially for people who would otherwise never get tested at all.
The limitations are worth naming. Finger-prick sampling is more prone to collection error than a venous draw, small volumes can restrict which additional markers a lab will run, and most consumer kits report total B12 without MMA, which means they cannot resolve the exact ambiguity that makes B12 testing tricky. A borderline home result usually ends with a clinician visit and a second test anyway. Our piece on how accurate at-home tests are covers the general accuracy question in more depth.
Reading your result and what comes next
A clearly low result with matching symptoms is straightforward: it warrants treatment and, importantly, a look at the cause. Low B12 is a finding, not a diagnosis. Whether it stems from diet, from medication, from autoimmune gastritis, or from an intestinal condition changes both the treatment route and whether it is lifelong. Testing for intrinsic factor antibodies is often part of that workup. High-dose oral B12 works well for most causes, including many cases of impaired absorption, because a small fraction is absorbed by passive diffusion independent of intrinsic factor. Injections remain standard for severe deficiency or clear neurological involvement.
A borderline result deserves either an MMA test or, if you are in a clearly at-risk group and symptoms fit, a trial of supplementation with retesting. A high result on its own is not a concern in someone taking supplements, since excess B12 is water soluble and largely excreted, though an unexplained high value in someone not supplementing occasionally points to a liver or blood condition worth investigating. In every case, bring the number to a clinician rather than acting on it alone. B12 is one of the few nutrient problems where getting the interpretation right early genuinely changes the outcome.
Frequently asked questions
Can I have a B12 deficiency with a normal blood count?
Yes. Neurological symptoms can appear before megaloblastic anemia develops, and adequate folate intake can normalize red blood cell size while a B12 deficiency continues. A normal complete blood count does not rule out B12 deficiency.
How long should I stop taking B12 before testing?
There is no single official interval, but testing while supplementing measures your supplement rather than your absorption. If the goal is to assess an underlying absorption problem, discuss timing with your clinician, as some recommend several weeks off. Never stop treatment for a diagnosed deficiency without medical advice.
Is methylmalonic acid testing necessary for everyone?
No. It is most useful when the serum B12 result is in the ambiguous range, roughly 200 to 400, or when symptoms suggest deficiency despite a normal-looking total. A clearly low or clearly high serum result usually does not require it.
Do I need to fast before a B12 test?
Fasting is generally not required for B12 alone, though it may be required for other tests bundled into the same panel. Stopping high-dose biotin supplements beforehand matters more than fasting does.
Are at-home B12 tests reliable?
Kits processed by certified laboratories can give reasonable total B12 values, but finger-prick collection introduces more variability than a venous draw, and most kits do not include methylmalonic acid. Treat a home result as a screen and confirm anything borderline or abnormal with a clinician.
This article is for educational purposes only and is not medical advice. Interpret laboratory results with a qualified healthcare professional, particularly if you have neurological symptoms.
References and Key Studies
How we researched this: Our editorial team reviewed peer-reviewed clinical research and independent health-authority guidance before writing and reviewing this article. Key studies are listed below so you can read the science yourself.
- Godfrey KM, et al. (2023). Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial. PLoS Med. PubMed: 38051700
- Hamza Ali AA, et al. (2025). The Neurological Sequelae of Vitamin B12 Deficiency: A Systematic Review and Randomized Controlled Trial. Cureus. PubMed: 40486314
- Finkelstein JL, et al. (2020). Anaemia and iron deficiency in pregnancy and adverse perinatal outcomes in Southern India. Eur J Clin Nutr. PubMed: 31296936
Further reading: NIH Office of Dietary Supplements fact sheet · More research on vitamin B12 (PubMed) · Google Scholar